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Abstract
Background: Preclinical osteoarthritis models where damage occurs spontaneously may better reflect the initiation
and development of human osteoarthritis. The aim was to assess the commercial pig as a model of spontaneous
osteoarthritis development by examining pain-associated behaviour, joint cartilage integrity, as well as the use of
porcine cartilage explants and isolated chondrocytes and osteoblasts for ex vivo and in vitro studies.
Methods: Female pigs (Large white x Landrace x Duroc) were examined at different ages from 6 weeks to 3–4
years old. Lameness was assessed as a marker of pain-associated behaviour. Femorotibial joint cartilage integrity
was determined by chondropathy scoring and histological staining of proteoglycan. IL-6 production and
proteoglycan degradation was assessed in cartilage explants and primary porcine chondrocytes by ELISA and
DMMB assay. Primary porcine osteoblasts from damaged and non-damaged joints, as determined by chondropathy
scoring, were assessed for mineralisation, proliferative and mitochondrial function as a marker of metabolic capacity.
Results: Pigs aged 80 weeks and older exhibited lameness. Osteoarthritic lesions in femoral condyle and tibial
plateau cartilage were apparent from 40 weeks and increased in severity with age up to 3–4 years old. Cartilage
from damaged joints exhibited proteoglycan loss, which positively correlated with chondropathy score. Stimulation
of porcine cartilage explants and primary chondrocytes with either IL-1β or visfatin induced IL-6 production and
proteoglycan degradation. Primary porcine osteoblasts from damaged joints exhibited reduced proliferative,
mineralisation, and metabolic capacity.
Conclusion: In conclusion, the commercial pig represents an alternative model of spontaneous osteoarthritis and
an excellent source of tissue for in vitro and ex vivo studies.
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Background
Osteoarthritis (OA) is an age-related joint disorder and the
most common degenerative joint disorder in the World
[1]. Characterised by degenerative loss of the articular car-
tilage, joint space narrowing, synovial inflammation and
bone remodelling [2], it is a leading cause of disability and
pain. Unfortunately, at present there are no available dis-
ease modifying OA drugs (DMOADs) [2, 3]. As an ageing
population OA is a major health concern since it limits in-
dependence, reduces an individual’s quality of life and puts
additional pressure on healthcare systems and elderly sup-
port services [4, 5] .
Critically, the development of DMOADs has been ham-
pered by a lack of understanding of the joint pathology in
early OA. Unfortunately, investigating early OA joint
pathology in humans is inherently difficult. Synovial tissue
and synovial joint fluid can be collected from early OA pa-
tients by arthroscopy procedures. However, OA diseased
cartilage and bone tissue of sufficient quantity can gener-
ally only be obtained from end-stage diseased patients
who are undergoing elective joint replacement surgery.
Cartilage tissue from end-stage OA patients is often highly
degraded and is therefore of questionable relevance to our
understanding of the central pathways that underpin the
initiation and development of early degenerative changes
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in the human OA joint. Furthermore, many of the in vivo
preclinical models that are utilised are artificial models [6]
where OA is experimentally induced either chemically or
surgically. Surgical induction of OA is achieved by desta-
bilising the joint through the surgical damage of joint
ligaments, for example anterior cruciate ligament tear in
the dog [7] or more recently in mice through the destabil-
isation of the medial meniscus (DMM model) [8, 9]. Al-
though these models are effective in inducing joint
damage, they more likely reflect changes seen in trau-
matically induced OA, where an injury has triggered
further damage, rather than age-related OA [6, 8, 10].
For studying age-related human OA onset, animal
models that spontaneously develop OA are likely to be
more translatable. Such translation is critical to the de-
velopment of new OA drugs. Indeed, the greatest reason
for late-stage failure of candidate drugs can be traced
back to failure of preclinical target validation studies to
translate in the clinic [11]. In this regard, the Dunkin
Hartley guinea pig is a notable example [12]. These ani-
mals develop OA without surgical, chemical or environ-
mental manipulation [12, 13]. However, the quantity of
joint tissue for ex vivo and in vitro studies can be limit-
ing. Spontaneous development of OA has also been
studied in large animals including horse [14] and dog
[15]. However, the major drawback with these models is
the long timescale for OA development, which can make
studies prohibitively expensive and ultimately unfeasible.
Furthermore, public resistance to the use of companion
animal species in biomedical research also presents add-
itional challenges.
In contrast to the above models, commercial pigs have
been reported to develop spontaneous joint pathologies
at a young age, resulting in pigs often being slaughtered
due to lameness [16]. However, no study had previously
examined whether the commercial pig develops signs of
OA joint damage. The aim of this study was two-fold.
Firstly, to assess pain-associated behaviour and femoroti-
bial joint pathology for signs of spontaneous develop-
ment of OA in commercial pigs from juvenile to older
adult. Secondly, to assess the potential utility of porcine
cartilage explants and isolated porcine chondrocytes and
osteoblasts for in vitro and ex-vivo preclinical studies.
Methods
Animals
Female pigs (Large white x Landrace x Duroc) aged 6–
10 wks (n = 8, weight 37.4 ± 1.4 kg), 17 wks (n = 6, weight
84.0 ± 2.2 kg), 40 wks (n = 6, weight 141.2 ± 4.2 kg), 63
wks (n = 8, weight 245.1 ± 9.0 kg), and 3–4 years (n = 7,
weight 230.6 ± 9.0 kg) purchased from JSR Genetics Ltd.
(Driffield, UK) were used in this pilot study to examine
the incidence of the development of osteoarthritis. For
comparison purposes animals were characterised by age
in to three groups: juvenile (age range 6–17 wk), adult
(40–80 wk), and older adult (3–4 years). The juvenile
and adult age groups were all gilts (female pigs that have
not been used for breeding), whilst the older adults were
ex-breeding sows. Ethical permission for the study was
granted by the University of Nottingham Animal Welfare
Ethical Review Body (AWERB). Pigs were group-housed
under directives set by the Department of Environment,
Food, and Rural Affairs (DEFRA), as specified in The Wel-
fare of Farmed Animals (England) Regulations 2007, thus
replicating the standards animals were housed in prior to
arrival at our facilities. Animals were checked daily by
qualified animal technicians. Pigs were provided with free
access to food and water and allowed to acclimatise to
their surroundings upon arrival at the University facilities
for a minimum of 2 weeks before being slaughtered by
electrical stunning followed by exsanguination. The 63
wk. animals were maintained for an extended period of
time (16–17 weeks), prior to euthanasia, to allow temporal
changes in animal behaviour to be assessed. In all animals,
after death had been confirmed, the stifles were removed
for examination and tissue collection.
Assessment of pain-associated behaviour
Different aspects of pig behaviour including lameness,
response to touch, willingness to ambulate and vocalisa-
tion were assessed as potential markers of behavioural
pain in juvenile, adult and older adult pigs. Each behav-
ioural aspect was incorporated into a scoring system and
assigned a value from 1 to 5 (Additional file 1: Table S1)
based on that used by Royal et al. [17]. Behavioural as-
sessment was carried out weekly and assessment ses-
sions typically lasted about an hour. On arrival at the
facility, pigs were allowed to acclimatise to the presence
of the scorer for between 5 and 10 min before behav-
ioural scoring was carried out. Observation of lameness
was carried out during weekly weighing procedures, with
animals encouraged to move by the animal technicians.
Similarly, the response to handling by the animal tech-
nician during the weighing process was used to record
the response to touch. All other scoring parameters
were collected on the same visit and prior to attempts
to weight the animals, with animals resting in their
home environment.
Chondropathy scoring
Femoral condyles and tibial plateaus of juvenile, adult,
and older adult porcine femorotibial joints were used for
chondropathy scoring. The lateral and medial surfaces of
the femoral condyles and tibial plateaus of the joint were
scored separately. Chondropathy scoring was performed
using two methodologies, namely Collin’s grading and
the revised Système Française D’Arthroscopie (SFA)
scoring method as described by Walsh and colleagues
Macfadyen et al. BMC Musculoskeletal Disorders           (2019) 20:70 Page 2 of 12
[18]. The Collin’s grading and SFA are macroscopic se-
verity scoring systems, which are based on an assess-
ment of OA changes in the articular surface, including
cartilage swelling, fibrillation and exposure of bone.
They have been widely validated in both mild and severe
OA [18–23]. As a comparison to human OA, the fem-
oral condyles and tibial plateau were also scored from
end-stage knee OA patients (n = 4), which were collected
from the Royal Orthopaedic Hospital (Birmingham) fol-
lowing ethical approval from the Research Ethics Com-
mittee (NRES 13/NE/0222). In subsequent experiments,
based on gross assessment, “damaged cartilage” was de-
fined as having evidence of fibrillation, equivalent to a
Collin’s grade score of greater than 2, or a revised SFA
score of more than 20. Cartilage defined as “undamaged”
had a normal, unbroken surface.
Safranin-O staining of femoral condyle proteoglycans
Femoral condyles from n = 8 adult animals were snap
frozen in liquid nitrogen immediately following slaughter
and stored at − 80 °C until cryostat processing. Cryosec-
tions (8 μm thick) were cut using a cryostat and trans-
ferred to slides to facilitate subsequent safranin-O/ fast
green staining. Staining was performed without fixation
as described previously [24].
Culture of primary porcine chondrocytes, osteoblasts and
cartilage explant
Primary porcine chondrocytes were isolated from ju-
venile (n = 6 animals) and older adult (n = 6 animals)
femoral condyle cartilage by collagenase digestion. In
brief, samples of cartilage were diced with a scalpel and
digested for 4 h in chondrocyte cell culture media
(DMEM supplemented with 10% FBS, 2mML-glutamine,
1% non-essential amino acids, 1% penicillin/streptomycin)
containing 2mg/ml sterile-filtered collagenase (Sigma Al-
drich, Poole, UK). The digested cartilage was filtered
through a sterile 40 μm cell strainer, placed in T75 culture
flasks with cell culture media and incubated at 37 °C, 5%
CO2. Media was refreshed every 3–4 days.
Osteoblasts were cultured out from subchondral bone
chips obtained from adult (n = 6) and older adult (n = 6)
pigs, based on a protocol we have previously used for
human OA subchondral bone osteoblast outgrowth [25]. In
brief, subchondral bone chips from damaged and non-
damaged porcine femoral condyles were incubated in
T75 culture flasks at 37 °C, 5% CO2 in osteoblast cell
culture media (DMEM supplemented with 10% FBS, 2mM
L-glutamine, 1% non-essential amino acids, 1% penicillin/
streptomycin, 2mM β-glycerophosphate, 50 μg/ml L-ascor-
bic acid, 10 nM dexamethasone and 1% amphotericin-B).
After 7–20 days of culture, osteoblast outgrowth was ob-
served and the bone chips were removed.
Cartilage explants were prepared using a cork borer to
cut cartilage discs (50mm diameter) from full thickness
sections of damaged and non-damaged femoral condyle
cartilage obtained from adult animals (n = 7) for sGAG
analysis. Cartilage explants were also prepared from older
adult animals (n = 5) for analysis of collagen mRNA and
for in vitro cytokine stimulation. Explant discs were placed
into 96-well cell culture plates in chondrocyte cell culture
media and incubated at 37 °C, 5% CO2.
1,9-dimethylmethylene blue (DMMB) proteoglycan
release assay
Sulphated glycosaminoglycan (sGAG) released from car-
tilage explant (n = 7 adult animals) was quantified via a
dimethylmethylene blue (DMMB) assay, as previously
described [26]. In brief, cartilage explants were allowed
to rest in chondrocyte media for 2–3 days before being re-
placed with fresh chondrocyte media and incubated for
48 h, after which time the supernatant was collected for
analysis. Shark chondroiten sulphate C (Sigma, UK) was
used to generate a standard curve and 40 μL of standards
and samples combined with 250 μL DMMB reagent
(0.24% sodium chloride, 0.3% glycine, 0.8% v/v hydro-
chloric acid, 0.0016% DMMB) and absorbance read at
550 nm using a microplate reader (Bio-Rad 680XR).
Quantification of mRNA expression by qRT-PCR
Total RNA was extracted from primary porcine chon-
drocytes using an RNA isolation kit (Roche High Pure
Isolation Kit) according to the manufacturer’s instruc-
tions. Total RNA was extracted from snap-frozen por-
cine femoral condyle cartilage tissue using ceramic
beads (Roche Green Beads) and a MagnaLyser instru-
ment in combination with a fibrous tissue RNA extrac-
tion kit (Qiagen). cDNA was subsequently generated
from 100 ng of total RNA (ReverAid RT cDNA synthesis
kit, Thermo Scientific) according to manufacturer’s instruc-
tions. Relative mRNA expression of the collagen genes
COL1A1 and COL2A1 were determined by qRTPCR using
a Roche Lightcycler 480® (Roche, Burgess Hill, UK),
normalised to cDNA concentration. The primer sequences
used were as follows: COL1A1 Forward: AGAAGAAGA
CATCCCACCAGTCA, Reverse: CGTCATCGCACAAC
ACATTG; COL2A1 Forward: GGCAACAGCAGGTTCA
CGTA, Reverse: CAATCATAGTCTGGCCCCACTT. All
samples were analysed in triplicate.
Alkaline phosphatase (ALP) assay
Cultured osteoblasts were lysed using cell lysis buffer
(150 mM Sodium Chloride, 1% triton x-100, 50 mM
Tris, pH 8.0) containing protease and phosphatase in-
hibitor cocktails (Sigma Aldrich, Poole, UK) and the pro-
tein concentration of cell extract determined using the
Bradford protein assay [27]. To 10 μl osteoblast lysate,
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100 μl of alkaline phosphatase substrate containing p-nitro-
phenylphosphate (pNNP) was added and incubated for 15
mins at 37 °C before being stopped by the addition of 20 μl
0.1M sodium hydroxide. Standards prepared from human
alkaline phosphatase diluted in 1mM magnesium chloride
solution were run in parallel. Absorbance was measured at
405 nm using a BioRad 680XR platereader.
Alizarin red mineralisation assay
Mineralisation of osteoblasts was determined by Alizarin
Red staining [28]. In brief, upon reaching confluence oste-
oblasts were grown for a further 3 weeks and then were
stained with 0.5% alizarin red staining solution (0.5%
Alizarin Red, 1% ammonia solution, pH 4.0) for 10min.
The cells were then washed in PBS and destained using
10% cetyl pryridium chloride (Sigma, UK) for 10min. The
absorbance of the supernatant was measured at 550 nm
on a BioRad 680XR platereader.
Mitochondrial assays
To isolate mitochondria, osteoblasts were resuspended
in 2 ml Buffer (100 mM potassium chloride, 50 mM Tris,
5 mM Magnesium Chloride, 1.8 mM ATP, 1 mM EDTA.
pH 7.2) and homogenised on ice for 4 min. The sample
was then centrifuged at 720 x g for 1 min to pellet any
cellular debris. The resultant supernatant was trans-
ferred to clean pre-cooled tube and centrifuged at 10000
x g for 5 min to pellet the mitochondria. The mitochon-
drial pellet was then resuspended in 400 μl buffer (225
mM sucrose, 44 mM potassium phosphate monobasic,
12.5 mM magnesium acetate, 6 mM EDTA). Maximal
mitochondrial ATP production was measured using a
96-well bioluminescence assay. In brief, 25 μl of the
mitochondrial sample was added to 110 μl Tris-EDTA buf-
fer, 25 μl ADP and 40 μl ATP reagent SL (Biothema ATP
Reagent SL Kit). All samples were run in triplicate and lu-
minescence measured using a FLUOstar plate reader.
Mitochondrial citrate synthase activity was measured based
on the kinetic production of 2-nitro-5-benzoic acid mea-
sured at an absorbance of 415 nm using a Bio-rad 680XR
microplate reader.
Statistical analysis
Statistical analysis was carried out using Graphpad Prism
software version 7.0. Chondropathy scores and lameness
scores were analysed using the Kruskall-Wallis non-para-
metric test, with post-hoc tests where appropriate. Pearson’s
correlation coefficient was used to determine the relation-
ship between proteoglycan loss and revised SFA chondro-
pathy score. In vitro and ex-vivo expression data was
analysed using unpaired t-tests with 1-way ANOVA used
for dose responses.
Results
Development of lameness as a marker of pain-associated
behaviour in the commercial pig
Lameness was assessed in pigs at three different age groups,
(i) juvenile (n = 6), (ii) adult 63 week old pigs (n = 6) and
(iii) older adults (n = 7). The adult pigs (63 week old) were
monitored at weekly intervals over a 16week period and
lameness assessed from age 64 to 80weeks, to allow tem-
poral changes in pain-associated behaviour to be observed.
Observational scoring of lameness indicators revealed no
indications of lameness in the youngest age group (juven-
ile). However, there was a significant increase (p < 0.05) in
the median lameness of both 80week adult and older adult
pigs, compared to juvenile pigs (Fig. 1a). Furthermore, there
was a significant (p < 0.01) increase in lameness score over
a timespan of 16 weeks in adult pigs from age 64 to 80
weeks old (Fig. 1b). Lameness in the older adult animals
was on average no greater than that observed in adult ani-
mals aged 80 wks (Fig. 1a). None of the animals responded
to touch in a manner that would be associated with pain or
discomfort, or differed in their willingness to ambulate.
Furthermore, vocalisation was not related to any pain or
discomfort as might be expected of other animals, such as
the rat [29] for which VAS scoring is more commonly used.
The commercial pig spontaneously develops signs of
osteoarthritic joint damage
Femorotibial joints from juvenile, adult, and older adult
commercial pigs were assessed for the presence and sever-
ity of OA lesions by chondropathy scoring using Collin’s
grading and a revised SFA scoring system. As a compari-
son to human OA, femoral condyles and tibial plateau
from end-stage human knee OA patients (n = 4) were
scored using the same chondropathy scoring system.
Chondropathy scoring showed an effect of age and
joint compartment on the development of joint damage
in the commercial pig. Using either Collin’s grading or
revised SFA showed a significant increase in the median
joint damage score in adult and older adult pigs, com-
pared to juvenile pigs (Fig. 2a, b). As expected, the great-
est joint damage was observed in the older adult pigs,
which exhibited grade II and grade III lesions in femoral
condyle cartilage (Fig. 2c). OA cartilage lesions devel-
oped on both tibial plateaus and femoral condyles, and
on both medial and lateral sides of the joint. However, in
the older adult pigs significantly greater median joint dam-
age was present on the medial side of the femoral condyles
and on the medial side of tibial plateau, compared to the
corresponding lateral compartments (p < 0.05) as scored
using revised SFA (Fig. 2a). In addition to cartilage lesions,
the joints of all older adult pigs animals, and the majority
(75%) of 80 week adult pigs exhibited bony nodules, indica-
tive of osteophyte formation (Fig. 2d). However, notably,
joint damage, even in the older adult pigs was lower than
Macfadyen et al. BMC Musculoskeletal Disorders           (2019) 20:70 Page 4 of 12
that observed in end-stage human knee OA (Collin’s
grade = 10.0 ± 1.1; SFA = 106.4 ± 10.8).
In order to further examine the pathology of these
lesions we prepared cryosections of femoral condyle
cartilage from n = 8 adult pigs which exhibited varying
degrees of joint damage, and stained the cartilage pro-
teoglycans with Safranin O. As expected, proteoglycan
staining was appreciably lower in the cartilage sections
prepared from pig joints that exhibited higher chondro-
pathy scores (Fig. 3a). We then assessed the relationship
between proteoglycan degradation and joint damage by
preparing cartilage explants from n = 7 adult pigs with
varying degrees of joint damage (femoral condyle SFA =
1.4, 2.1, 3.2, 7.6, 11.2, 13.4 and 30.5) and measuring the
release of sGAGs, compared to non-damaged cartilage
explant. Due to the requirement to obtain full thickness
cartilage explants of the same size (50 mm diameter) we
did not determine sGAG release from explants of joints
with higher chondropathy scores. Therefore, a limitation
is that we have not assessed the relationship between
cartilage explant sGAG release across the full range of
joint damage scores in these animals. Nevertheless, the
relative release of sGAGs was positively correlated with
both Collin’s grade (r2 = 0.791, p < 0.01) and revised SFA
score (r2 = 0.733, p < 0.05) (Fig. 3b).
Cytokine stimulation of primary porcine chondrocytes
and cartilage explant induces IL-6 release and
proteoglycan degradation
Since human OA cartilage degeneration has been attrib-
uted to the hypertrophy and increased proliferative activity
of chondrocytes, we first examined whether chondrocytes
from the damaged joints of older adult pigs exhibited a
greater proliferative capacity. Comparing primary porcine
chondrocytes isolated from older adult pigs with those iso-
lated from juvenile animals, there was no difference in
proliferation rate (Fig. 4a). However, similar to primary
human chondrocytes, upon 2D culture porcine primary
cells rapidly adopted a fibroblast-like morphology (Fig. 4b)
and exhibited a significantly lower ratio of COL2A1 to
COL1A1 expression compared to cartilage (Fig. 4c;
p < 0.05), suggesting that the porcine chondrocyte pheno-
type is not maintained in culture.
Next in porcine femoral condyle cartilage explants and
isolated porcine chondrocytes obtained from older adult
animals, we examined their utility as ex-vivo and in vitro
OA models by determining the effect of putative pro-in-
flammatory drivers of OA cartilage degeneration on the re-
lease of the pro-inflammatory cytokine IL-6 (by ELISA) and
sGAG release (by DMMB assay). Stimulation for 24 h of
primary porcine chondrocytes with either recombinant por-
cine IL-1β (0.1 ng/ml to 3 ng/ml) or recombinant visfatin
(500 ng/ml) significantly increased IL-6 secretion, com-
pared to unstimulated control (Fig. 4d). Similarly, 24 h
stimulation of porcine cartilage explants with either recom-
binant IL-1β (0.1 ng/ml to 1 ng/ml) or visfatin (500 ng/ml)
significantly induced IL-6 secretion (Fig. 4e), compared to
unstimulated control cells. In addition, 24 h stimulation of
porcine cartilage explant with IL-1β significantly induced
the release of sGAGs (Fig. 4f).
Porcine subchondral osteoblasts from OA damaged joints
exhibit reduced proliferative and metabolic capacities
and reduced ability to mineralise
The presence of bony nodules in adult animals indicated
the involvement of bone in the development of joint prob-
lems in the pig. In human OA, the presence of osteophytes
and changes to the subchondral bone trabecular structure
has been attributed to an altered osteoblast phenotype [30].
Fig. 1 Development of lameness as a marker of behavioural pain. A
scoring system was used to assess lameness as a marker of
behavioural pain. a Comparison of median lameness score in
juvenile (n = 6 animals), 80 wk. adult (n = 6 animals) and older adult
(n = 7 animals) pigs. * = p < 0.05, significantly different from juvenile
lameness score as determined by Kruskal-Wallis non-parametric test
with Dunn’s post-hoc test. b Median lameness score in adult pigs
across an 16 week timespan from age 64 to 80 wk. old (n = 6
animals). ** = p < 0.01, significant change in median score over time
as determined by Kruskal-Wallis test
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Therefore, we next compared the phenotype of osteoblasts
isolated from both damaged and non-damaged joints from
both adult and older adult pigs.
The proliferative rate of osteoblasts obtained from
non-damaged adult joints was significantly (p < 0.01)
greater than in osteoblasts from the older adult damaged
joints (Fig. 5a). In addition, the osteoblasts from
non-damaged adult joints, but not osteoblasts from the
damaged older adult joints, were able to form mineralised
bone nodules over 21 d culture as noted by positive stain-
ing of mineral with Alizarin red (Fig. 5b). Furthermore,
while not statistically significant, a trend for osteoblasts
from damaged older adult joints to exhibit greater ALP
activity than osteoblasts from adult non-damaged joints
was observed (P = 0.09; Fig. 5c).
To investigate this further, we next examined mitochon-
drial activity by determining both mitochondrial ATP
production and citrate synthase activity in osteoblasts from
damaged and non-damaged joints collected either adult or
older adult pigs. There was a highly significant (p < 0.01) ef-
fect of joint damage on both mitochondrial ATP produc-
tion (Fig. 5d) and citrate synthase activity (Fig. 5e), with
osteoblasts from damaged joints exhibiting reduced mito-
chondrial ATP production and citrate synthase activity,
compared to osteoblasts from non-damaged joints, in both
adult and older adult pigs.
Discussion
This study is the first to report the temporal and spontan-
eous development of OA in the femorotibial joint of the
commercial pig and its association with behavioural pain.
Furthermore, for the first time we provide evidence of im-
paired proliferative, metabolic and mineralisation capacity of
subchondral osteoblasts from OA damaged joints in the pig.
Fig. 2 Spontaneous development of joint damage in the commercial pig. a Median total and joint compartment chondropathy score of femoral condyle
and tibial plateau joints using Collin’s grading and Revised SFA in juvenile (white boxes, n= 6), adult (light grey boxes, n= 14) and older adult (dark grey
boxes, n= 7) pigs. * = p< 0.05; ** = p< 0.01; *** = p< 0.001 significantly different compared to juvenile animals. ψ= p< 0.05 significantly different between
medial and lateral compartment within same age group, as determined using Kruskal-Wallis non-parametric test. b Representative images of femoral condyle
joints from juvenile, adult, and older adult animals. c Evidence of Grade II and Grade III cartilage lesions in femoral condyles of older adult pigs d Evidence of
bony nodules in adult pigs. FCM= femoral condyle medial, FCL = femoral condyle lateral, TPM= tibital plateau medial, TPL = tibial plateau lateral
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Examination of porcine femorotibial joints by two dif-
ferent chondropathy scoring systems (revised SFA and
Collin’s grade) revealed that commercial pigs develop
osteoarthritic lesions in their femorotibial joints early in
their lifespan. Importantly, significantly greater total car-
tilage damage was observed on the medial side of the
joint compared to the lateral compartments in the older
adult pigs, as often observed in the development of hu-
man OA knee which has been attributed to gait [10].
Similarly to human OA, articular cartilage from dam-
aged pig joints exhibited lower proteoglycan content
than that collected from non-damaged joints. In human
OA, cartilage proteoglycan matrix degradation is attrib-
uted to the proliferation and hypertrophy of chondro-
cytes. In this study, we observed no difference in the
proliferative capacity of porcine primary chondrocytes
isolated from juvenile joints compared to chondrocytes
isolated from damaged older adult pig joints. However,
similarly to human OA chondrocytes [31–33] porcine
chondrocytes rapidly de-differentiated in culture, exhi-
biting a fibroblast-like morphology and expressed sig-
nificantly lower type II collagen compared to porcine
cartilage.
In addition to cartilage damage, the joints of adult pigs
exhibited bony nodules indicative of osteophyte formation
and aberrant subchondral bone remodelling [34]. Evi-
dence of abnormalities in the subchondral bone early in
the development of joint damage in the pig adds further
weight to the role of bone in the initiation and progression
of OA [2, 35, 36]. In human OA, the appearance of bony
spurs can be seen on radiographs of the diseased joint,
whilst MRI analysis has shown that the presence of bone
marrow lesions in subchondral bone are associated with
the progression of cartilage loss [37, 38] and pain [39, 40].
Further analysis by MicroCT has shown that the subchon-
dral bone in OA is under-mineralised but has thicker tra-
beculae [41], suggestive of accelerated bone turnover. In
addition to our findings in the pig, changes to the sub-
chondral bone have been reported during the spontaneous
development of OA in the Dunkin Harltey guinea pig
[42], where bone changes were found to occur prior to
significant cartilage loss [43].
In this study, further evidence for the involvement of
bone in the spontaneous development of OA in the pig was
observed upon analysis of isolated porcine osteoblasts from
the subchondral bone tissue of damaged joints and
non-damaged joints. Both proliferative and mineralisation
capacity was found to be impaired in osteoblasts from dam-
aged joints of older adult animals compared to osteoblasts
from younger non-damaged joints. Conversely, osteoblasts
Fig. 3 Areas of cartilage damage exhibit proteoglycan loss. a Representative images (10X magnification) of Safranin O staining of proteoglycan in
femoral medial condyle cryosections from n = 8 adult pigs with varying signs of joint damage. White numbers represent SFA of the femoral
condyle joint (medial plus lateral). Yellow numbers represent the SFA score of the whole joint (femoral condyle and tibial plateau). b Correlation
between chondropathy scoring (SFA and Collins) and sGAG release from femoral condyle cartilage explants prepared from n = 7 adult pig joints.
sGAG release was measured by DMMB assay and is expressed as the relative fold difference in damaged cartilage compared to healthy
undamaged control cartilage explant. r = Pearson’s correlation coefficient
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from damaged joints of older adult animals exhibited
greater ALP activity compared to osteoblasts from younger
non-damaged joints. It is important to note however, that
we did not compare the proliferative activity of osteoblasts
from damaged and non-damaged joints within the same
age group. We cannot therefore be certain whether this
impaired proliferative osteoblast phenotype is due to age
or disease. However, this “damaged” porcine osteoblast
Fig. 4 Characterisation of porcine chondrocytes and cartilage explant. a Proliferation of primary porcine chondrocytes isolated from juvenile
(n = 6) and older adult pigs (n = 6). Proliferation was determined by MTS assay over a timecourse of 14 days. (B) Representative light microscope
image (6.3X magnification) of porcine chondrocytes in 2D culture showing fibroblast-like morphology. c mRNA expression of type I and Type II
collagen in primary porcine chondrocytes (n = 6 animals) compared to non-damaged porcine cartilage explant (n = 5 animals), from older adult
pigs. Expression was determined by qRT-PCR normalised to total cDNA concentration. d Secretion of IL-6 from porcine primary chondrocytes from
older adult pigs (n = 6) stimulated for 24 h with recombinant IL-1β (0.1–3 ng/ml) or recombinant visfatin (500 ng/ml). IL-6 in cell supernatants was
measured by ELISA. * = p < 0.05; *** = p < 0.001 significantly different from un-stimulated control chondrocytes. Bars represent mean ± SEM (n = 6). e
Secretion of IL-6 from porcine non-damaged cartilage explants from older adult pigs stimulated for 24 h with recombinant IL-1β (0.1–10 ng/ml) or
recombinant visfatin (500mg/ml) as measured by ELISA. * = p < 0.05; *** = p < 0.001 significantly different from un-stimulated control explants. Bars
represent mean ± SEM (n = 20 explants per stimulant). f Detection of sulphated glycosaminoglycan (sGAG) proteoglycan side-chain upon 24 h
stimulation of porcine non-damaged cartilage explant from older adult pigs with recombinant IL-1B. sGAG detected by DMMB assay. * = p < 0.05; ***
= p < 0.001 significantly different from un-stimulated control explants. Bars represent mean ± SEM (n = 20 explants per stimulant)
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phenotype has similarities to the human OA osteoblast
phenotype. For example, human OA subchondral osteo-
blasts have elevated ALP activity, compared to non-OA
osteoblasts [44]. Furthermore, Sanchez et al. [45] have
found that osteoblasts from regions of sclerotic sub-
chondral bone tissue exhibit greater ALP activity and
reduced mineralization, compared to non-sclerotic osteo-
blasts from OA joints. This high ALP activity but lower
mineralisation capacity in OA osteoblasts has been attrib-
uted to the potential accumulation of pyrophosphate (PPi)
activating ALP, whilst being a potent inhibitor of hydro-
xyapaptite crystal formation [45].
It has previously been proposed that the phenotype of
elevated ALP coupled with reduced mineralisation in OA
osteoblasts indicates that subchondral bone osteoblasts
undergo incomplete differentiation in human OA [46].
Since mitochondrial activity plays a critical role in osteo-
blast differentiation [47, 48] it is notable that we found
that osteoblasts from damaged pig joints exhibited signifi-
cantly lower mitochondrial ATP production than osteo-
blasts from non-damaged joints. Mitochondrial activity
has been implicated as a mediator of OA pathology [49,
50]. Indeed, reduced mitochondrial activity in OA chon-
drocytes has been implicated in cartilage damage [51].
Currently, despite mitochondrial activity being central to
osteoblast differentiation, studies investigating mitochon-
dria in OA osteoblasts are lacking. However, osteoblast
mitochondrial dysfunction has been identified as an im-
portant factor in the pathogenesis of osteoporosis [52].
Our finding that citrate synthase activity was also reduced
in osteoblasts from damaged pig joints suggests joint dam-
age in the pig was associated with a reduction in subchon-
dral osteoblast mitochondrial number, rather than
osteoblast mitochondrial dysfunction.
In addition to the spontaneous development of OA joint
damage, the commercial pig represents an excellent tissue
source for in vitro and ex-vivo OA models. Indeed, cultured
osteoblasts retained a “damaged” dysfunctional phenotype
in vitro. Furthermore, although isolated chondrocytes rap-
idly de-differentiated upon 2D culture, both chondrocytes
and cartilage explants were highly responsive to stimulation
with pro-inflammatory putative OA drivers including IL-1β
and visfatin, with a rapid quantitative secretion of IL-6, and
sGAG release. Critically, such studies on human cartilage
most often utilise tissue from end-stage OA patients where
the cartilage is highly degraded. Therefore, the availability
of sufficient quantity of relatively healthy cartilage tissue
that behaves in a similar manner may represent a useful
tissue source for conducting studies that better represent
early OA initiation.
Fig. 5 a Proliferation of osteoblasts obtained from non-damaged adult and damaged older adult pig joints measured over a 14 day time period
by MTS assay. Data points represent the mean cell number ± SEM (n = 3). b Representative light microscope images of alizarin red stained
osteoblasts isolated from non-damaged adult and damaged older adult joints. c ALP activity isolated from non-damaged adult (n = 3 animals)
and damaged older adult joints (n = 3 animals). Values represent mean ALP activity ± SEM. d Maximal mitochondrial ATP production in osteoblasts
obtained from adult (n = 3 non-damaged; n = 3 damaged) and older adult (n = 3 non-damaged; n = 3 damaged) pig joints. ** = p < 0.01. Bars
represent mean ± SEM. e Citrate synthase activity in osteoblasts obtained from adult (n = 3 non-damaged; n = 3 damaged) and older adult
(n = 3 non-damaged; n = 3 damaged) pig joints. Bars represent mean ± SEM. ** = p < 0.01, *** = p < 0.001
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The use of the commercial pig as a spontaneous model
of OA has some limitations. Pigs can develop osteochon-
drosis (OC), which commonly occurs in fast growing ani-
mals and can lead to the development of OA which is
secondary [53]. Also, while the Large white x Landrace x
Duroc, as used in the current study, is commonly utilized
for commercial purposes, it is feasible that differences in
the development of OA could be seen between different
genotypes of pig. A limitation of the current study is the
narrow range of recombinant proteins considered in our
ex vivo assays. The response of cartilage explants from the
pig femorotibial joint to alternative proteins implicated in
the etiology of human osteoarthritis remains to be con-
firmed. Furthermore, the cytokine stimulations of porcine
chondrocytes and cartilage explant were conducted in full
serum culture media. This was done in order to mimic
previous studies in on cytokine stimulation of human car-
tilage and human chondrocytes [54, 55]. However, it
should be noted that Bian et al. showed that cartilage ex-
plant cultured in full-serum exhibited 70% greater degrad-
ation over the course of 2 weeks compared to cartilage in
serum-free media [56]. Finally, it remains to be deter-
mined whether histological examination of the subchon-
dral bone of the pig femorotibial joint will reveal similar
pathophysiological changes as evident in humans.
Conclusion
The commercial pig spontaneously develops behavioural
pain and OA joint damage in the femorotibial joint with
evidence of cartilage lesions in the femoral condyles and
tibial plateau and metabolically dysfunctional subchondral
bone osteoblasts. The commercial pig may therefore
provide an alternative preclinical model of OA and a
highly useful source of joint tissue for in vitro and ex
vivo OA models.
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